Johnson & Johnson to Pay Oregon for Defective Motrin

The state of Oregon will receive more than $400,000 to resolve a lawsuit against Johnson & Johnson regarding an undercover recall of defective Motrin pills. Stoll Berne worked with the Oregon Department of Justice in the matter.

In 2008, Johnson & Johnson discovered that a plant in Puerto Rico had manufactured Motrin pills that were not dissolving properly.  This issue meant that the potency of the drug may have been compromised.

The company hired "secret shoppers" to buy the defective products off of store shelves as opposed to issuing a public recall. Once exposed, the Oregon Department of Justice sued the company and two subsidiaries in 2011 under the state's unlawful trade practices act because of the risk that Oregon consumers would not get the pain relief that Johnson &Johnson had promised. A formal recall was issued long after discovery of the defective batch amid U.S. Food and Drug Administration pressure.

"We are honored to have assisted the Oregon Department of Justice in this matter and are pleased with the outcome and resolution," said Jen Wagner, Stoll Berne attorney for the state of Oregon.

RECENT NEWS:

May 12, 2017: FiercePharma, J&J strikes settlement in 'phantom' Motrin recall suit
May 11, 2017: Reuters, J&J resolves lawsuit by Oregon over 'phantom' Motrin recall
May 11, 2017: Koin News, Johnson & Johnson settles suit over Motrin buyback
May 11, 2017: The Oregonian, Johnson & Johnson agrees to pay over $400K to state in flawed Motrin lawsuit, records show